Not all decisions are equally important. Neither are your information needs. There are times when you need information—plus real experience, real insight, and pragmatic solutions that will withstand the scrutiny of the most senior pharma and biotech executives. That’s when you need Healogix.

From early-stage product development to brand rejuvenation, Healogix delivers pragmatic, commercially viable business strategies for life sciences companies. We apply unparalleled industry experience—more than 75 years—to development and marketing questions along the entire product lifecycle.

When you're determining the clinical endpoints for a Phase III program, evaluating a major licensing opportunity, or investigating why a product isn't hitting its forecast, you need more than data and insight; you need information you can present and act on with confidence. That’s the Healogix advantage.

Harris Kaplan, CEO, was instrumental in developing and launching more than 75 new Rx products, including blockbusters Lipitor, Viagra, Crestor, Rituxan, Nexium, Norvasc and Herceptin. He heads a seasoned team of consultants and researchers who have expertise in both the pharma and biotech industries.